Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura-Reference-Cited by-同舟云学术

Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura

Published:2019-12 Issue:6 Volume:58 Page:102665
ISSN:1473-0502
Container-title:Transfusion and Apheresis Science
language:en
Short-container-title:Transfusion and Apheresis Science

Author:

Garraud Olivier^ORCID,Malot Sandrine,Herbrecht Raoul,Ojeda-Uribe Mario,Lin Jin-Sying,Veyradier Agnès,Payrat Jean-Marc,Liu Kathy,Corash Laurence^ORCID,Coppo Paul

Funder

French Ministry of Health

Programme Hospitalier de Recherche Clinique

Cerus

Publisher

Elsevier BV

Subject

Hematology

Reference46 articles.

1. Thrombotic thrombocytopenic purpura;Joly;Blood,2017

2. Thrombotic thrombocytopenic purpura;Kremer Hovinga;Nat Rev Dis Primers,2017

3. Thrombotic thrombocytopenic purpura: basic pathophysiology and therapeutic strategies;Crawley;Hematol Am Soc Hematol Educ Program,2013

4. Management of thrombotic thrombocytopenic purpura: current perspectives;Blombery;J Blood Med,2014

5. Comparison and stability of ADAMTS13 activity in therapeutic plasma products;Scott;Transfusion,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Congenital thrombotic thrombocytopenic purpura and recombinant ADAMTS13;Japanese Journal of Thrombosis and Hemostasis;2024

2. Clinical Manifestations, Current and Future Therapy, and Long-Term Outcomes in Congenital Thrombotic Thrombocytopenic Purpura;Journal of Clinical Medicine;2023-05-09

3. Congenital thrombotic thrombocytopenic purpura: genetics and emerging therapies;Annals of Blood;2022-01

4. Impact of pathogen-reduction technologies on COVID-19 convalescent plasma potency;Transfusion Clinique et Biologique;2021-05